NSRX short interest
Nasus Pharma Ltd. · Healthcare · Medical - Pharmaceuticals · settlement date 2026-09-30
| Shares short | 78,238 |
|---|---|
| Change vs prior report | -2,295 (-2.9%) |
| Change over six months | -21.1% |
| Days to cover | 2.87 (sector: 3.78) |
| Average daily volume | 27,246 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
NSRX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 78,238 | -2.9% | 2.87 | 27,246 |
| 2026-09-15 | 80,533 | -7.7% | 7.96 | 10,116 |
| 2026-08-31 | 87,272 | -39.6% | 5.90 | 14,783 |
| 2026-08-14 | 144,506 | -9.7% | 8.18 | 17,670 |
| 2026-07-31 | 160,076 | -6.2% | 15.16 | 10,559 |
| 2026-07-15 | 170,667 | -0.9% | 11.81 | 14,454 |
| 2026-06-30 | 172,140 | -3.0% | 6.89 | 25,001 |
| 2026-06-15 | 177,466 | +2.9% | 4.14 | 42,908 |
| 2026-05-29 | 172,484 | +11.3% | 3.10 | 55,723 |
| 2026-05-15 | 155,032 | +39.6% | 2.14 | 72,447 |
| 2026-04-30 | 111,022 | +71.0% | 1.00 | 188,552 |
| 2026-04-15 | 64,912 | -34.6% | 2.20 | 29,511 |
| 2026-03-31 | 99,202 | +771.7% | 1.00 | 810,304 |
| 2026-03-13 | 11,380 | +28.2% | 2.72 | 4,188 |
| 2026-02-27 | 8,874 | +69.9% | 1.96 | 4,538 |
| 2026-02-13 | 5,224 | +19.1% | 1.35 | 3,858 |
| 2026-01-30 | 4,385 | +99.0% | 1.00 | 6,061 |
| 2026-01-15 | 2,204 | -58.4% | 1.00 | 6,488 |
| 2025-12-31 | 5,300 | +174.2% | 1.00 | 10,839 |
| 2025-12-15 | 1,933 | -36.9% | 1.48 | 1,303 |
| 2025-11-28 | 3,063 | -17.9% | 1.24 | 2,467 |
| 2025-11-14 | 3,732 | -10.2% | 1.21 | 3,095 |
| 2025-10-31 | 4,158 | -63.0% | 2.29 | 1,816 |
| 2025-10-15 | 11,248 | -49.0% | 1.33 | 8,443 |
| 2025-09-30 | 22,067 | +1268.1% | 1.00 | 59,473 |
import finzdata as yf
yf.Ticker("NSRX").short_interest # every report since 2017
yf.Client().short_interest(["NSRX"], start="2018-01-01")Healthcare short interest · NSRX price history · Who owns NSRX · All short interest